期刊文献+

2型糖尿病模型GK大鼠骨形态学和生物力学特点观察 被引量:3

Bone Histomorphometric and Biomechanical Analyses in Type 2 Diabetic Goto-Kakizaki Rats
下载PDF
导出
摘要 目的观察2型糖尿病模型GK大鼠的骨代谢特点以及骨密度和骨生物力学特性的变化。方法采用雄性6月龄GK大鼠10只,以月龄、性别匹配的健康Wistar大鼠作为正常对照。颈静脉取血检测与骨代谢有关的生化指标。DXA法测定股骨和腰椎骨密度,并行股骨三点弯曲实验和腰椎压缩实验。甲基丙烯酸甲酯包埋胫骨干骺端以制备不脱钙骨切片。应用多媒体病理图像分析软件进行骨组织形态计量学分析。结果GK大鼠体重明显低于健康对照Wistar大鼠(P<0.01)。与对照组相比,GK大鼠血清骨钙素水平明显降低[(4.97±0.49,6.75±0.71)μg/mL,P<0.01],而抗酒石酸酸性磷酸酶活性明显升高[(17.92±5.23,8.31±2.69)U/L,P<0.01],但血钙和血磷无明显变化(P>0.05);股骨和腰椎骨密度显著降低[(0.16±0.01,0.22±0.02;0.12±0.01,0.16±0.02)g/cm2,P<0.01];骨强度和腰椎的弹性模量明显降低(P<0.01)。骨形态学分析显示GK大鼠股骨长度和第五腰椎高度分别降低10.3%和9.5%(P<0.01),股骨和腰椎横截面积无明显变化(P>0.05)。骨组织形态计量学分析显示,GK大鼠骨小梁体积、骨小梁厚度、类骨质表面和厚度明显降低[(15.72±1.18,19.13±1.13)%,(61.91±4.54,74.43±3.63)μm,(18.18±1.25,19.63±1.07)%,(3.68±0.48,4.34±0.35)μm,P<0.01或0.05],动态参数如矿化表面、矿化沉积率和骨形成率也明显降低[(17.77±1.54,19.56±2.07)%,(1.07±0.22,1.35±0.16;0.20±0.03,0.26±0.04)μm/day,P<0.05或0.01],而矿化延迟时间显著延长(2.66±0.56,2.12±0.35,P<0.05)。结论非肥胖的GK大鼠表现有骨量减少和骨折危险性增加;2型糖尿病本身可干扰成骨细胞功能和活性而导致骨重建失衡。 Objective To characterize the bone metabolism in Goto-Kakizaki (GK) rats, a spontaneous type 2 diabetic model. Methods Ten six-month old male GK rats were enrolled, with ten age- and sex-matched non-diabetic Wistar rats as controls. Blood samples were collected from the carotid artery for analysis of calcium, phosphate, osteocalcin and tartrate-resistant acid phosphatase activity. Bone mineral density was assessed by a dual energy X-ray absorptiometry at the femur and the fifth vertebral body, respectively, followed by biomeehanieal studies. The metaphyseal tibiae were embedded in methylmethaerylate to obtain undecaleified sections. Histomorphometric analysis was performed with an analysis software for multimedia pathological image. Results The body weight was much lower in the GK rats than that in the healthy Wistar rats ( P 〈 0.01 ). Compared with the controls, the GK rats had significantly lower serum osteoealein concentration [ (4.97±0.49, 6.75 ± 0.71 ) μg/mL] and higher tartrate-resistant acid phosphatase activity [ (17.92 ±5.23, 8.31± 2.69) U/L], both were P 〈 0.01. Bone density at the femur and lumbar vertebra was significantly deceased in the diabetic rats [ (0.16± 0.01, 0.22 ± 0.02; 0.12 ± 0.01, 0.16 ± 0.02) g/cm^2 , P 〈 0.01]. Bone morphologic analysis showed that the lengths of femur and lumbar were reduced by 10.3% and 9.5%, respectively, in the GK rats (P 〈 0.01 ), while no significant difference was seen in the values of cross-sectional area at both sites (P 〉 0.05). Histomorphometrical study showed significantly decreased trahecular bone volume, trabeeular thickness, osteoid surface and thickness in GK rats [ (15.72± 1.18,19.13±1.13)%, (61.91 ± 4.54, 74.43 ± 3.63) μm, (18.18 ± 1.25, 19.63± 1.07)%, (3.68± 0.48, 4.34 ± 0.35) μm, P 〈 0.01 or 0.05], respectively. Further, the mineralizing surface, mineral apposition rate and bone formation rate were also decreased in the GK rats compared with those in the controls [(17.77± 1.54, 19.56±2.07)%, (1.07±0.22, 1.35±0.16; 0.20±0.03, 0.26±0.04) μm/day, P〈0.05 or P〈 0.01 ], along with an increase in mineralization lag time (2.66± 0.56, 2.12 ± 0.35, P 〈 0.05 ). Conclusion Nonobese GK rats develop bone mass loss with increased risk of bone fracture. Type 2 diabetes mellitus per se may induce disequilibrium of bone remodelling by interfering with the function and activity of osteoblasts.
出处 《中国实验动物学报》 CAS CSCD 2008年第5期361-365,共5页 Acta Laboratorium Animalis Scientia Sinica
关键词 骨密度 骨生物力学 骨组织形态计量学 骨丢失 2型糖尿病 GK大鼠 Bone density Bone biomechanies Bone histomorphometry Bone loss Type 2 diabetes mellitus GK rat
  • 相关文献

参考文献20

  • 1Rakic V, Davis WA, Chubb SA, et al. Bone mineral density and its determinants in diabetes: the Fremantle Diabetes Study [ J]. Diabetologia, 2006. 49(5): 863- 871.
  • 2王芬,何华亮,刘铜华.自发的2型糖尿病动物模型[J].中国实验动物学报,2007,15(5):395-398. 被引量:14
  • 3Ahmad T, Ohlsson C, Saaf M, et al. Skeletal changes in type-2 diabetic Goto-Kakizaki rats [J]. J Endocrinol, 2003, 178( 1 ) : 111 - 116.
  • 4Amir G, Rosenmann E, Sherman Y, et al. Osteoporosis in the Cohen diabetic rat: correlation between histomorphometric changes in bone and microangiopathy [J]. Lab Invest, 2002, 82(10):1399- 1405.
  • 5Erben RG. Embedding of bone samples in methylmethacrylate: an improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry [ J ]. J Histochem Cytochem, 1997, 45 (2) :307 - 313.
  • 6Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry : standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee [J]. J Bone Miner Res, 1987, 2(6):595-610.
  • 7Hanley DA, Brown JP, Tenenhouse A, et al. Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: crosssectional results from the Canadian Multicentre Osteoporosis Study [J]. J Bone Miner Res, 2003, 18(4) :784 - 790.
  • 8Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis [J]. Osteoporos Int, 2007, 18(4) :427 - 444.
  • 9Portha B. Programmed disorders of beta-cell development and function as one cause for type 2 diabetes? The GK rat paradigm [J]. Diabetes Metab Res Rev, 2005, 21(6):495- 504.
  • 10Fuse H, Fukumoto S, Sone H, et al. A new synthetic steroid, osaterone acetate (TZP-4238), increases cortical bone mass and strength by enhancing bone formation in ovariectomized rats [ J ]. J Bone Miner Res, 1997, 12(4) :590- 597.

二级参考文献28

  • 1薛长勇,大坂寿雅,井上修二.2型糖尿病Goto-Kakizaki大鼠低三酰甘油血症及其作用途径[J].中国临床康复,2006,10(8):79-81. 被引量:7
  • 2刘毅,王宗保.糖尿病肾病动物模型的研究进展[J].中国实验动物学报,2006,14(1):67-70. 被引量:21
  • 3吴国亭,徐倍.磺脲类药物对2型糖尿病大鼠心肌组织磺脲类药物受体表达的影响[J].上海医学,2006,29(4):217-221. 被引量:4
  • 4张红敏,陈世伟,谢春光,谢毅强,邓西方.参芪复方抗自发性糖尿病GK大鼠早期动脉粥样硬化的作用机制[J].中国中药杂志,2006,31(15):1272-1276. 被引量:35
  • 5Seiea RM, Suzuki KI. Impaired insulin secretion in isolated islets of Goto-Kakizaki rats, an animal model of non-obese type 2 diabetes, is a primary event [J]. Acta Medica Portuguesa, 2004, 17:42 -48.
  • 6Calderari S, Gangnerau MN, Meile M J, et al. Is defective pancreatic beta-cell mass environmentally programmed in Goto-Kakizaki rat model of type 2 diabetes? Insight from crossbreeding studies during suckling period[J].Pancreas, 2006, 33:412 - 417.
  • 7Patricia S, Marle-Noelle G, Made-Helene G, et al. Impaired pancreatic β cell function in the fetal CK rat [J]. J Clin Invest, 1998, 101:899 - 904.
  • 8Annika M, Claes-Goran O, Bodin B, et al. Lack of compensatory increase in islet blood flow and islet mass in GK rats following 60% partial pancreatectomy [J]. J Endocrinol, 2005, 184:19 - 327.
  • 9Momosc K, Nunomiva S, Nakata M, et al. Immunohistochemical and electron-microscopic observation of beta-cells in pancreatic islets of spontaneously diabetic Goto-Kakizaki rats [ J ]. Med Mol Morphol, 2006, 39:146- 153.
  • 10Motoi K, Ryu-ichi W, Hiroyasu S, et al. Accelerated loss of islet β cells in sucrose-fed Goto-Kakizaki rats, a genetic model of noninsulin- dependent diabetes mellitus [J]. Am J Pathol, 1998, 153: 537 - 545.

共引文献13

同被引文献52

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部